Cambria Investment Management’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.28M Buy
50,380
+16,904
+50% +$385K 0.06% 267
2026
Q1
$716K Buy
33,476
+4,160
+14% +$86.6K 0.04% 292
2025
Q4
$627K Sell
29,316
-8,891
-23% -$182K 0.04% 349
2025
Q3
$640K Buy
38,207
+7,641
+25% +$115K 0.04% 303
2025
Q2
$439K Sell
30,566
-849
-3% -$11.6K 0.03% 331
2025
Q1
$455K Buy
31,415
+446
+1% +$6.33K 0.03% 204
2024
Q4
$406K Buy
+30,969
New +$428K 0.02% 275

Other funds holding MD

Cambria Investment Management's MD Position: Q2 2026 in Review

Cambria Investment Management increased its Pediatrix Medical (MD) stake by 50% in Q2 2026, buying an estimated $385K and bringing the position to 50,380 shares worth $1.28M. The position accounts for 0.06% of the portfolio, ranked #267.

Cambria Investment Management first reported a position in MD in Q4 2024 and has held it in 7 quarters since. 304 funds tracked by Wall St. Rank hold MD as of Q2 2026.

  • Cambria Investment Management held 50,380 shares of Pediatrix Medical worth $1.28M as of Q2 2026.
  • Cambria Investment Management bought 16,904 Pediatrix Medical shares in Q2 2026, an estimated $385K.
  • Pediatrix Medical made up 0.06% of Cambria Investment Management's portfolio in Q2 2026, its #267 holding.
  • Cambria Investment Management first reported a position in Pediatrix Medical in Q4 2024 and has held it in 7 quarters since.
  • 304 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.

Based on Cambria Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.